Hepatitis C Helped to Enter Human Liver Cells by New Molecule

FOR IMMEDIATE RELEASE
Los Angeles, California, United States of America (Free-Press-Release.com) January 29, 2012 -- The Center for the Biology of Chronic Disease (CBCD) has recently learned that
a molecule in the membrane of human liver cells that helps cholesterol absorption also happens to permit the entry of hepatitis C virus (HCV). The University of Illinois at Chicago College of Medicine conducted this research.

According to the researchers, this cholesterol receptor could be a new target for anti-viral therapy. Amazingly, a drug for cholesterol which already exists may help in combating an HCV infection. The drug, ezetimibe which is FDA approved, and that is sold under the brand name Zetia is already widely available.

The CBCD is encouraged by this development. The center believes it may help in the fight against chronic HCV infection. Much of the center’s research focuses on the role viruses play in chronic disease. In fact, the center encourages biologists, virologists, geneticists and scientists in general to obtain a copy of Dr. Hanan Polansky’s book. The name of the book is “Microcompetition with Foreign DNA and the Origin of Chronic Disease” and is available as a free download from the CBCD website. ( http://www.cbcd.net )

The theory identifies the origin of many chronic diseases, such as hepatitis, atherosclerosis, stroke, cancer, obesity, diabetes, multiple sclerosis, lupus, thyroiditis, osteoarthritis, rheumatoid arthritis, and alopecia.

"Even if only a portion of the author's thesis is correct, it would establish wholly new insights into the pathogenesis of chronic disease states, and would have significant implications for treatment and/or prevention." - Kim E. Barrett, PhD - Professor of Medicine and Vice-Chair for Research, Department of Medicine, University of California, San Diego, School of Medicine.

The CBCD upholds Dr. Hanan’s theory and is quite aware of the ramifications of supporting new theories.

The Center for the Biology of Chronic Disease (CBCD, http://www.cbcd.net) is a research center recognized by the IRS as a 501(c)(3) non-for-profit organization. The mission of the CBCD is to advance the research on the biology of chronic diseases, and to accelerate the discovery of treatments for these diseases.

We invite biologists, virologists, scientists everywhere to download Dr. Polansky's book, "Microcompetition with Foreign DNA and the Origin of Chronic Disease" here: http://cbcd.net/

The CBCD published the “Purple” book by Dr. Hanan Polansky. The book presents Dr. Polansky’s highly acclaimed scientific theory on the relationship between the DNA of latent (chronic) viruses and the onset of chronic diseases. Dr. Polansky’s book is available as a free download from the CBCD website.

Chronic Disease     disease     hbv     HCV     hepatitis     Hepatitis Remedy     virus